Welcome to the Coalition for Clinical Trial Equity
About Us
The Coalition for Clinical Trial Equity is a collaborative initiative launched by the Foundation for Sarcoidosis Research (FSR) to address disparities in clinical trial participation, particularly among Black Americans. Our mission is to foster a more inclusive research landscape by dismantling barriers and increasing representation of Black patients in clinical trials. Through collective efforts, we seek to pave the way for more equitable access to clinical trials and ultimately improve health outcomes for Black patients.
Our Goals
The coalition's key objectives are to work together to develop strategies that advance several key recommendations for clinical trial equity stemming from prior research.
Our goals are to:
Our Steering Committee
Our coalition is led by a diverse and experienced Steering Committee, comprising leaders from various professional societies, patient organizations, and academic institutions, renowned bioethicists, patient advocates, and clinicians. They bring with them robust backgrounds in health equity and a commitment to advancing diversity in clinical trials.
The Steering Committee spearheads three work groups focused on dismantling specific barriers identified by Black patients:
- The FMLA Advocacy & Corporate Infrastructure group will focus on ensuring job security and fostering employer engagement to incentivize support for clinical trial participants.
- The Patient Education & Engagement group will prioritize trust-building and patient education efforts.
- The Patient Benefit & Compensation group will strive to broaden compensation practices, ensuring accessibility for all patients irrespective of their support system, income, or employment status.
Meet Our Steering Committee:
COALITION FOR CLINICAL TRIAL EQUITY STEERING COMMITTEE ROSTER 2024
Adam Anderson, MD, Washington University in St. Louis
Andrew Berman, MD, Rutgers New Jersey Medical School
Ann Chauffe DO, MPH, FACR, Boehringer Ingelheim
Arthur Caplan, PhD, NYU Grossman School of Medicine
Brandon Moss, MD, Cleveland Clinic Foundation
Brian McBride, PharmD, Mallinckrodt Pharmaceuticals
Charles S. Modlin, Jr., MD, MBA, MetroHealth
Connie Lee, PSY.D., Alliance to Cure Cavernous Malformation
Divya Patel, DO, University of Florida Health, Gainesville
Donald Richards, MD, Cedars-Sinai Medical Center
Ennis James, MD, Medical University of South Carolina
Jennifer Miller, PhD, Yale School of Medicine
Jessica Propps, FSR Ignore No More Patient Advocate
John Laughner, American Heart Association
Kathryn Washington, MPH Patient, FSR Ignore No More Patient Advocate
Logan Harper, MD, Cleveland Clinic
Mary Oldham, FSR Ignore No More Patient Advocate
Nana Afari-Armah, MD, MedStar Washington Hospital Center (MedStar Health)
Ogugua Obi, MD, MPH, MSc Eastern North Carolina Health
Peter Sporn, MD, Northwestern Medicine
Priscilla Rodriguez, MPH, EveryLife Foundation
Purvis Hunt, MA, Ignore No More Patient Advocate
Rachel Barron, Global Genes Rare Foundation Alliance
Sonya Charles, PhD, Cleveland State University
Stuart Sweet, MD, MPH, American Thoracic Society
Tracey Newman, National Medical Fellowships, Inc.
Yvette Cozier, DSc, MPH, Boston University
Join Us
With a commitment to advancing diversity in clinical trials, we strive to improve health outcomes for all communities. The Steering Committee is actively collaborating to build out strategies in preparation for the coalition’s launch January 2025. For more information about the coalition, how to join and sponsorship opportunities, please complete our brief interest form.
Together, we can make a difference in advancing health equity and improving healthcare outcomes for all.
Founding DEI Coalition Member/Sponsor
Partner dedicated to the advancement of clinical trial diversity.
General DEI Coalition Member/Sponsor
Partner dedicated to the advancement of clinical trial diversity.
Made possible in part by grants from the Chan Zuckerberg Initiative and Boehringer Ingelheim.
Actions by the coalition do not necessarily reflect endorsement by every individual coalition member organizations, but reflects consensus by the coalition and coalition members.